Amrutanjan Health Care Limited has informed the Exchange regarding 'Intimation on rolling out of the revised Second Phase ESOP 2 of the existing ESOPScheme of the company by the name of Amrutanjan Health Care Limited Employees StockOption Scheme 2020 '.
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amrutanjan Health Care Limited's Board has approved the revised Second Phase of its ESOP Scheme 2020, targeting 44 employees at top and middle management levels. The plan covers 200,000 equity shares spread over 5 years (FY27-FY31), with vesting tied to sales targets. The grant price is Rs. 502 per share, representing a 10% discount to the NSE closing price of Rs. 558 on May 7, 2026. First-time grantees receive 10% allocation without vesting conditions after one year. The scheme will be implemented through an ESOP Trust, with shares bought from the secondary market. The last exercise window is October 2031.
This ESOP aligns management interests with shareholders by tying rewards to company performance and sales targets. The 200,000 share allocation represents potential dilution, though new shares will be purchased from the secondary market rather than freshly issued.